TikTok-Viral Botox Alternative – SheKnows


If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission.

For decades people have had a love-hate relationship with wrinkles. Some celebrate every new one, while others want to zap them as soon as possible: both are fine, as long as you feel confident in your own skin. Now, some people who prefer to zap their wrinkles may be hesitant to go under the knife. Luckily, there’s always TikTok to help us find the answer — and the answer is an anti-wrinkle patch from Amazon.

Related story

Salicylic Acid Scalp Treatments Are The Latest TikTok Trend – We’ve Found A $15 Option That Combats Oil And Dry Flakes

Many people were curious about anti-wrinkle pads, so much so that TikTok was inundated with videos of people trying them out for themselves. A blogger with the handle @marinaannsimone showed her results after both short-term and long-term use, and it’s safe to say that a lot of people wanted to try it for themselves. You can watch his video HERE.

So what are these magic tampons that people use instead of Botox? They’re adorably called Frownies and the best part is that they’re only $21 on Amazon.

Image loaded lazily

Courtesy of Frownies

Frownies anti-wrinkle patches for the forehead and between the eyes


on Amazon.com

Buy now


Frownies Forehead and Between Eye Wrinkle Patches are non-invasive paper face patches that allow you to wake up wrinkle-free. With 144 patches, it was considered one of the perfect ways to prepare for an important day, with many TikTokers claiming that long-term treatment definitely showed a difference.

With over 19,000 reviews and over 12,000 five and four stars, it’s no wonder this viral product has become a staple in so many people’s routines.

Depending on the brand, you apply the patch to your skin overnight or in the morning with their rose water (or plain water) to help stick it on for an extended period of time.

Before you go, check out our gallery below:


Comments are closed.